Predictive relationship of phagocytic activity to tumor regression in indoloquinolinone derivative-treated mice.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002244:Carbon / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005260:Female; D007211:Indoles / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008657:Metabolic Clearance Rate; D051379:Mice; D012157:Mononuclear Phagocyte System / Q000276:immunology; D010587:Phagocytosis / Q000187:drug effects*
D000970:Antineoplastic Agents; D007211:Indoles; D002244:Carbon